Dr. Hannah Valantine, MD

Publications

• Transdiscipliry translatiol science and the case of preterm birth, 2013

• Proliferation sigl inhibitors and post-transplant maligncies in heart transplantation, 2011

• Decisions, Decisions: How Program Diversity Influences Residency Program Choice, 2011

• Impact of Donor-Transmitted Atherosclerosis on Early Cardiac Allograft Vasculopathy, 2011

• Identification and Classification of Acute Cardiac Rejection by Intragraft Transcriptiol Profiling, 2011

• Universal noninvasive detection of solid organ transplant rejection, 2011

• Academic Couples: Implications for Medical School Faculty Recruitment and Retention, 2011

• Differentially Expressed R from Public Microarray Data Identifies Serum Protein Biomarkers, 2010

• Gene-Expression Profiling for Rejection Surveillance after Cardiac Transplantation, 2010

• Changing trends in infectious disease in heart transplantation, 2010

• Right Ventricular Dysfunction Predicts Poor Outcome Following Hemodymically Compromising Rejection, 2009

• New developments in immunosuppressive therapy for heart transplantation, 2009

• Twenty-year survivors of heart transplantation at Stanford University, 2008

• Effect of rapamycin therapy on corory artery physiology early after cardiac transplantation, 2008

• Asymmetric dimethylarginine and cardiac allograft vasculopathy progression: Modulation by sirolimus, 2008

• Determints of lumen loss between years 1 and 2 after cardiac transplantation, 2007

• Outcome in cardiac recipients of donor hearts with increased left ventricular wall thickness, 2007

• Molecular testing for long-term rejection surveillance in heart transplant recipients, 2007

• Cytomegalovirus-associated allograft rejection in heart transplant patients, 2007

• Is there a role for proliferation sigl, 2007

• Frequent occult infection with cytomegalovirus, 2007

• Changes in corory atomy and physiology after heart transplantation, 2007

• Interplay between systemic inflammation, 2007

• Changes in corory arterial dimensions early after cardiac transplantation, 2007

• Pulmory nocardiosis in a heart transplant patient: Case report and review of the literature, 2007

• Peripheral blood leukocyte counts in cytomegalovirus infected heart transplant patients, 2006

• Giant corory aneurysms in heart transplantation, 2006

• T-cell immunity to subclinical cytomegalovirus infection reduces cardiac allograft disease, 2006

• Acute rejection and cardiac allograft vascular disease is reduced by suppression of subclinical, 2006

• Discordant changes in epicardial and microvascular corory physiology after cardiac transplantation, 2006

• Wound healing complications with de novo sirolimus versus mycophenolate mofetil, 2006

• Validation of a screening protocol for identifying low-risk c, 2006

• Recurrence of iron deposition in the cardiac allograft in a patient with non-HFE hemochromatosis, 2006

• Use of the implantable cardioverter-defibrillator in long, 2005

• Induction therapy for pediatric and adult heart transplantation, 2005

• From clinical trials to clinical practice, 2005

• Certican (Everolimus) in heart transplantation

• Prevention of cardiac allograft vasculopathy with Certican((R)) (everolimus), 2005

• Cardiac allograft vasculopathy after heart transplantation: Risk factors and magement, 2004

• Glucose intolerance, as reflected by hemoglobin A(1c) level, 2004

• Cytomegalovirus infection impairs the nitric oxide synthase pathway, 2004

• The role of viruses in cardiac allograft vasculopathy, 2004

• Alysis of survivors more than 10 years after heart transplantation in the cyclosporine era, 2004

• Longer-term risks associated with 10, 2003

• Cardiac allograft vasculopathy: Central role of endothelial injury leading to transplant atheroma, 2003

• Post-operative conversion from cyclosporine to tacrolimus in heart transplantation, 2003

• Preferential involvement of larger vessels in a rat model of diabetes induced graft vasculopathy, 2002

• Conversion of cyclosporine to tacrolimus for refractory or persistent myocardial rejection, 2002

• Mycophenolic acid concentrations in long-term heart transplant patients, 2002

• Reversal of diabetes-induced rat graft transplant corory artery disease by metformin, 2002

• Detection of early atherosclerosis with radiolabeled monocyte chemoattractant protein, 2001

• Impact of cytomegalovirus hyperimmune globulin on outcome after cardiothoracic transplantation, 2001

• Transplant corory artery disease - A novel model independent of cellular alloimmune response, 2001

• Detection and treatment of corory artery disease in liver transplant candidates, 2001

• Mild hyperhomocysteinemia is not associated with cardiac allograft corory disease, 2001

• Severe tricuspid regurgitation after heart transplantation, 2001

• Metabolic abnormalities characteristic of dysmetabolic syndrome predict the development of, 2001

• Impact of type 1 diabetes on microvascular vs. macrovascular involvement with TXCAD, 2001

• Neoral use in the cardiac transplant recipient, 2000

• Impact of prophylactic immediate posttransplant ganciclovir on development of transplant, 1999

• Role of CMV in transplant corory artery disease and survival after heart transplantation., 1999

• Diabetes and dyslipidemia - A new model for transplant corory artery disease, 1998

• Scedosporium apiospermum (Pseudallescheria boydii) infection in a heart transplant recipient, 1998

• Importance of decreased heart rate in predicting transplant corory artery disease, 1997

• Individualizing immunosuppression for heart transplantation: Strategies for the next decade, 1997

• Heart transplantation in patients over 54 years of age - Mortality, morbidity and quality of life, 1997

• Methotrexate or total lymphoid radiation, 1997

• Significant reduction in the number of fungal infections after lung-, heart-lung, 1997

• Volume-mediated pulmory responses in liver transplant candidates, 1996

• Early Doppler echocardiographic dysfunction is associated with an increased mortality after, 1996

• Induction of nitric oxide synthase, 1996

• Corory artery intimal thickening in the transplanted heart, 1996

• Prophylactic ganciclovir treatment reduces fungal as well as cytomegalovirus infections after heart, 1995

• The relationship of granzyme A and perforin expression to cardiac allograft rejection, 1995

• PROGNOSTIC IMPORTANCE OF INTIMAL THICKNESS AS MEASURED BY INTRACORORY ULTRASOUND AFTER CARDIAC, 1995

• Incidence and progression of transplant corory artery disease over 1 year, 1995

• Role of lipids in allograft vascular disease, 1995

• MAGNETIC-RESONCE IMAGING, 1995

• PREVENTION AND TREATMENT OF CYTOMEGALOVIRUS DISEASE IN THORACIC ORGAN TRANSPLANT PATIENTS, 1995

• CORRELATION OF DONOR CHARACTERISTICS WITH TRANSPLANT CORORY, 1995

• CLINICAL OUTCOME OF INTERVAL CADAVERIC REL-TRANSPLANTATION IN CARDIAC ALLOGRAFT RECIPIENTS, 1995

• CARDIAC ALLOGRAFT VASCULAR-DISEASE, 1995

• Distribution and morphologic features of corory artery disease in cardiac allografts, 1995

• INCIDENCE AND SEVERITY OF TRANSPLANT CORORY, 1995

• FEASIBILITY OF SERIAL INTRACORORY ULTRASOUND IMAGING FOR ASSESSMENT OF PROGRESSION OF INTIMAL, 1994

• IMPACT OF CYCLOSPORINE DOSE ON LONG-TERM OUTCOME AFTER HEART-TRANSPLANTATION, 1994

• CYTOKINES AS POTENTIAL MEDIATORS OF ACUTE ALLOGRAFT DIASTOLIC DYSFUNCTION IN CYCLOSPORINE, 1994

• Cytokine gene expression in human cardiac allograft recipients., 1994

• CARDIAC TRANSPLANTATION - THE STANFORD EXPERIENCE IN THE CYCLOSPORINE ERA, 1994

• EXERCISE ECHOCARDIOGRAPHY IN HEAT TRANSPLANT RECIPIENTS, 1994

• METABOLIC RISK-FACTORS FOR ATHEROSCLEROSIS IN HEART-TRANSPLANT RECIPIENTS, 1994

• RECOVERY OF THE RIGHT VENTRICLE AFTER SINGLE-LUNG TRANSPLANTATION IN PULMORY-HYPERTENSION, 1994

• INFLUENCE OF GRAFT-REJECTION ON INCIDENCE OF ACCELERATED GRAFT CORORY, 1993

• INTRACORORY ULTRASOUND IMAGING IN HEART-TRANSPLANT RECIPIENTS - THE STANFORD EXPERIENCE, 1992

• INTRACORORY ULTRASOUND IN CARDIAC TRANSPLANT RECIPIENTS, 1992

• COST CONTAINMENT - COADMINISTRATION OF DILTIAZEM WITH CYCLOSPORINE AFTER HEART-TRANSPLANTATION, 1992

• NITROGLYCERIN-INDUCED CORORY VASODILATION IN CARDIAC TRANSPLANT RECIPIENTS, 1992

• SENSITIVITY AND SPECIFICITY OF DIASTOLIC INDEXES FOR REJECTION SURVEILLANCE, 1991

• FREQUENCY AND MECHANISM OF BRADYCARDIA IN CARDIAC TRANSPLANT RECIPIENTS AND NEED FOR PACEMAKERS, 1991

• CHANGES IN CARDIAC MORPHOLOGY AND FUNCTION FOLLOWING SINGLE-LUNG TRANSPLANTATION, 1991

• LEFT-VENTRICULAR DIASTOLIC FUNCTION, 1990

• Variability of Doppler echocardiographic indexes of left ventricular filling, 1990

• SERIAL MEASUREMENT OF INTEGRATED ULTRASONIC BACKSCATTER IN HUMAN CARDIAC ALLOGRAFTS FOR THE, 1990

• CARDIAC TRANSPLANTATION IN PATIENTS WITH PREEXISTING NEOPLASTIC DISEASES, 1990

• Long-term magement and results in heart transplant recipients., 1990

• Prevalence of accelerated corory artery disease, 1989

• RECURRENCE OF AMYLOID IN A CARDIAC ALLOGRAFT 4 MONTHS AFTER TRANSPLANTATION, 1989

• FREQUENCY OF FAMILIAL TURE OF DILATED CARDIOMYOPATHY AND USEFULNESS OF CARDIAC TRANSPLANTATION IN, 1989

• INCREASING PERICARDIAL-EFFUSION IN CARDIAC TRANSPLANT RECIPIENTS, 1989

• INCREASED BETA-RECEPTOR DENSITY AND IMPROVED HEMODYMIC, 1989

• A HEMODYMIC AND DOPPLER ECHOCARDIOGRAPHIC STUDY OF VENTRICULAR-FUNCTION IN LONG, 1989

• CARDIAC TRANSPLANTATION, 1989

• Changes in Doppler echocardiographic indexes of left ventricular function, 1987

• Cardiac sarcoidosis: response to steroids and transplantation., 1987